What is Zacks Research’s Forecast for Integer Q4 Earnings?

Integer Holdings Co. (NYSE:ITGR) – Equities research analysts at Zacks Research increased their Q4 2024 earnings per share (EPS) estimates for shares of Integer in a research note issued to investors on Tuesday, January 7th. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will post earnings of $1.46 per share for the quarter, up from their prior estimate of $1.45. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q3 2026 earnings at $1.65 EPS.

ITGR has been the subject of a number of other reports. Citigroup upped their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Truist Financial lifted their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Bank of America upped their price objective on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Finally, Piper Sandler reiterated an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research note on Friday, October 25th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $145.44.

Integer Stock Performance

NYSE ITGR opened at $133.13 on Friday. The company has a fifty day moving average price of $135.73 and a 200-day moving average price of $127.72. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 1.99 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer has a 1 year low of $94.56 and a 1 year high of $142.76.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.27 earnings per share.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Contravisory Investment Management Inc. grew its holdings in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 80 shares in the last quarter. Huntington National Bank boosted its position in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. Quest Partners LLC grew its stake in Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 332 shares in the last quarter. Versant Capital Management Inc increased its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares during the period. Finally, GAMMA Investing LLC lifted its stake in Integer by 74.1% in the 3rd quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 278 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.